New Advances in Managing COPD | TIME
Mar 18, 2024 · From innovative new lung valves to refinements in the deployment of inhaled therapies and vaccines, the landscape of COPD care and treatment is changing.
A New COPD Treatment is FDA Approved
Jul 8, 2024 · On June 26, 2024, Verona Pharmaceuticals announced that its new medication, Ensifentrine (Ohtuvayre), was approved by the U.S. Food and Drug Administration (FDA) for the maintenance treatment of Chronic Obstructive Pulmonary Disease (COPD). See …
COPD News Today Home | COPD News Today
KT-621, potential oral medication for COPD, cleared for human trials. The U.S. Food and Drug Administration has cleared the start of clinical trial testing of KT-621, Kymera Therapeutics’ oral therapy for chronic obstructive pulmonary disease (COPD) and other diseases marked by type 2 …
Chronic obstructive pulmonary disease - Latest research and news …
Chronic obstructive pulmonary disease (COPD) is a disease of the respiratory tract that is characterized narrowing of the small airways and destruction of lung tissue. This leads to poor...
COPD News - ScienceDaily
4 days ago · Latest research news on COPD, including chronic bronchitis, chronic obstructive airway disease, chronic obstructive lung disease and emphysema.
Lung Disease News -- ScienceDaily
3 days ago · Latest medical research on lung disease. Learn about the symptoms of chronic obstructive pulmonary disease (COPD), emphysema, and lung cancer along with the latest treatment information.
News on chronic obstructive pulmonary disease - Medical Xpress
News on chronic obstructive pulmonary disease. Diseases, Conditions, Syndromes. Increased focus on comorbidities, socioeconomic factors could help improve health equity for people with COPD.
2024 GOLD Report Reflects New Research on COPD Management
Dec 8, 2023 · The 2024 GOLD Report, “Global Strategy for Prevention Diagnosis and Management of COPD,” not only includes guideline updates that reflect the latest research on chronic obstructive pulmonary disease (COPD); it also reflects some shifts in thinking about what’s important in COPD treatment, according to Claus Vogelmeier, MD, a lead report ...
Dupixent found to prevent COPD exacerbations in Phase 3 trial
Apr 3, 2023 · Dupixent (dupilumab) — a medication initially approved for exzema — was found to significantly reduce the number of disease exacerbations and to improve lung function in people with chronic obstructive pulmonary disease (COPD), meeting the primary and key secondary goals of the pivotal Phase 3 BOREAS trial. A similarly designed study, the ...
COPD News - Index - Medscape
Oct 14, 2024 · Medscape Medical News, October 14, 2024. CHEST 2024 Hospitalized COPD Patients With GERD Have Better Outcomes The surprise finding hints that anti–acid reflux therapy may provide benefit in COPD...
- Some results have been removed